Edwin C Thrower1, Fred S Gorelick, Sohail Z Husain. 1. Department of Internal Medicine, Section of Digestive Diseases, Yale University School of Medicine, New Haven, CT 06520, USA.
Abstract
PURPOSE OF REVIEW: This review focuses on studies from the past year that highlight molecular and cellular mechanisms of pancreatic injury arising from acute and chronic pancreatitis. RECENT FINDINGS: Factors that induce or ameliorate injury as well as cellular pathways involved have been examined. Causative or sensitizing factors include refluxed bile acids, hypercalcemia, ethanol, hypertriglyceridemia, and acidosis. In addition, the diabetes drug exendin-4 has been associated with pancreatitis, whereas other drugs may reduce pancreatic injury. The intracellular events that influence disease severity are better understood. Cathepsin-L promotes injury through an antiapoptotic effect, rather than by trypsinogen activation. In addition, specific trypsinogen mutations lead to trypsinogen misfolding, endoplasmic reticulum stress, and injury. Endogenous trypsin inhibitors and upregulation of proteins including Bcl-2, fibroblast growth factor 21, and activated protein C can reduce injury. Immune cells, however, have been shown to increase injury via an antiapoptotic effect. SUMMARY: The current findings are critical to understanding how causative factors initiate downstream cellular events resulting in pancreatic injury. Such knowledge will aid in the development of targeted treatments for pancreatitis. This review will first discuss factors influencing pancreatic injury, and then conclude with studies detailing the cellular mechanisms involved.
PURPOSE OF REVIEW: This review focuses on studies from the past year that highlight molecular and cellular mechanisms of pancreatic injury arising from acute and chronic pancreatitis. RECENT FINDINGS: Factors that induce or ameliorate injury as well as cellular pathways involved have been examined. Causative or sensitizing factors include refluxed bile acids, hypercalcemia, ethanol, hypertriglyceridemia, and acidosis. In addition, the diabetes drug exendin-4 has been associated with pancreatitis, whereas other drugs may reduce pancreatic injury. The intracellular events that influence disease severity are better understood. Cathepsin-L promotes injury through an antiapoptotic effect, rather than by trypsinogen activation. In addition, specific trypsinogen mutations lead to trypsinogen misfolding, endoplasmic reticulum stress, and injury. Endogenous trypsin inhibitors and upregulation of proteins including Bcl-2, fibroblast growth factor 21, and activated protein C can reduce injury. Immune cells, however, have been shown to increase injury via an antiapoptotic effect. SUMMARY: The current findings are critical to understanding how causative factors initiate downstream cellular events resulting in pancreatic injury. Such knowledge will aid in the development of targeted treatments for pancreatitis. This review will first discuss factors influencing pancreatic injury, and then conclude with studies detailing the cellular mechanisms involved.
Authors: V P Singh; A K Saluja; L Bhagat; G J van Acker; A M Song; S P Soltoff; L C Cantley; M L Steer Journal: J Clin Invest Date: 2001-11 Impact factor: 14.808
Authors: Vijay P Singh; Gary D Bren; Alicia Algeciras-Schimnich; David Schnepple; Sarah Navina; Stacey A Rizza; Rajinder K Dawra; Ashok K Saluja; Suresh T Chari; Santhi S Vege; Andrew D Badley Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-03-12 Impact factor: 4.052
Authors: Y Wang; L Sternfeld; F Yang; J A Rodriguez; C Ross; M R Hayden; F Carriere; G Liu; W Hofer; I Schulz Journal: Gut Date: 2008-10-20 Impact factor: 23.059
Authors: Eva Kereszturi; Richárd Szmola; Zoltán Kukor; Peter Simon; Frank Ulrich Weiss; Markus M Lerch; Miklós Sahin-Tóth Journal: Hum Mutat Date: 2009-04 Impact factor: 4.878
Authors: Petra Pallagi; Viktória Venglovecz; Zoltán Rakonczay; Katalin Borka; Anna Korompay; Béla Ozsvári; Linda Judák; Miklós Sahin-Tóth; Andrea Geisz; Andrea Schnúr; József Maléth; Tamás Takács; Mike A Gray; Barry E Argent; Julia Mayerle; Markus M Lerch; Tibor Wittmann; Péter Hegyi Journal: Gastroenterology Date: 2011-09-03 Impact factor: 22.682
Authors: Marta Herreros-Villanueva; Elizabeth Hijona; Jesus Maria Bañales; Angel Cosme; Luis Bujanda Journal: World J Gastroenterol Date: 2013-02-07 Impact factor: 5.742
Authors: Song Han; Ella W Englander; Guillermo A Gomez; Judith F Aronson; Cristiana Rastellini; R P Garofalo; Deepthi Kolli; Thomas Quertermous; Ramendra Kundu; George H Greeley Journal: Am J Physiol Gastrointest Liver Physiol Date: 2013-05-16 Impact factor: 4.052